Chris Powell
About Chris Powell
Chris Powell is a scientist specializing in vector process development, currently employed at Adaptimmune. He holds a Master's degree in Chronic Disease and Immunity from the University of Leicester and has extensive experience in microbiology and analytical process development.
Current Role at Adaptimmune
Chris Powell currently serves as a Scientist in Vector Process Development at Adaptimmune. He has held this position since 2020, contributing to advancements in gene and cell therapy. His role involves developing processes that are critical for the production of vectors used in therapeutic applications.
Previous Experience in Analytical Process Development
Prior to his current role, Chris worked at Adaptimmune as a Scientist in Analytical Process Development from 2019 to 2020. In this capacity, he focused on the analytical methodologies necessary for evaluating the quality and efficacy of therapeutic products.
Educational Background in Chronic Disease and Immunity
Chris Powell earned a Master's degree in Chronic Disease and Immunity from the University of Leicester, studying from 2016 to 2017. This program provided him with a strong foundation in understanding the complexities of chronic diseases and their immunological aspects.
Experience in Microbiology and Research
Chris has a diverse background in microbiology and research. He worked as a Microbiology Laboratory Technician at Exova Group plc from 2013 to 2014 and as a Microbiology Research Technician at Campden BRI from 2014 to 2016. Additionally, he served as a Research Technician at the University of Leicester for four months in 2019, where he investigated the role of novel genes in rare diseases such as uveal melanoma.
Academic Qualifications in Biological Sciences
Chris completed his undergraduate studies at the University of Lincoln, where he obtained a degree in Bioveterinary Science from 2009 to 2012. This educational background laid the groundwork for his career in the biological sciences and research.